Showing 1 - 5 results of 5 for search 'Hilary M Collins', query time: 0.03s Refine Results
  1. 1
    Novel Semi-Synthetic Cu (II)–Cardamonin Complex Exerts Potent Anticancer Activity against Triple-Negative Breast and Pancreatic Cancer Cells via Inhibition of the Akt Signaling Pathway

    Novel Semi-Synthetic Cu (II)–Cardamonin Complex Exerts Potent Anticancer Activity against Triple-Negative Breast and Pancreatic Cancer Cells via Inhibition of the Akt Signaling Pat... by Md Shahadat Hossan, Mohammed Khaled Bin Break, Tracey D. Bradshaw, Hilary M. Collins, Christophe Wiart, Teng-Jin Khoo, Ahmed Alafnan

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Correction: PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs.

    Correction: PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs. by Frances R Wadelin, Joel Fulton, Hilary M Collins, Nikolaos Tertipis, Andrew Bottley, Keith A Spriggs, Franco H Falcone, David M Heery

    Published 2015-01-01
    Get full text
    Article
  3. 3
    PRAME is a golgi-targeted protein that associates with the Elongin BC complex and is upregulated by interferon-gamma and bacterial PAMPs.

    PRAME is a golgi-targeted protein that associates with the Elongin BC complex and is upregulated by interferon-gamma and bacterial PAMPs. by Frances R Wadelin, Joel Fulton, Hilary M Collins, Nikolaos Tertipis, Andrew Bottley, Keith A Spriggs, Franco H Falcone, David M Heery

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Correction to “Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy”

    Correction to “Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy” by Haneen Abuzaid, Salah Abdelrazig, Lenny Ferreira, Hilary M. Collins, Dong-Hyun Kim, Kuan-Hon Lim, Toh-Seok Kam, Neil R. Thomas, Lyudmila Turyanska, Tracey D. Bradshaw

    Published 2023-12-01
    Get full text
    Article
  5. 5
    PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer

    PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer by Tianyan Wang, Martuza Sarwar, Jonathan B Whitchurch, Hilary M Collins, Tami Green, Julius Semenas, Amjad Ali, Christopher J Roberts, Ryan D Morris, Madlen Hubert, Madlen Hubert, Sa Chen, Zahra El-Schich, Anette G Wingren, Thomas Grundström, Richard Lundmark, Nigel P Mongan, Nigel P Mongan, Lena Gunhaga, David M Heery, Jenny L Persson, Jenny L Persson, Jenny L Persson

    Published 2022-03-01
    Get full text
    Article

Search Tools: